InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 192155

Wednesday, 10/01/2014 2:19:07 AM

Wednesday, October 01, 2014 2:19:07 AM

Post# of 345605

The same with the early mention of Bavi's possible use in Alzheimer as a way to get to the brain and pass the brain-blood barrier (I think Roche even has a video out showing what role PS plays there).



I thought the same, especially because the video never mentioned the "exact" drug and its not like Roche to leave out details, unless way back at this time they had a long ways to go to ensure Peregrine does not lift off till the timing is right...

---------------

Who the hell knows why and for what reason or degrees of separation this may be---- but ...

take a look at Video #1 from Roche (discusses the blood brain barrier with no "SPECIFIC" mention of a drug...



--------------------------------------------------------

Now for Video #2, take a look at our infamous Bavi MOA video:

http://vimeo.com/84073332

-------------------------------------------------------

Now, doing what I try to do... to the best of my ability is connect some dots, where no dots are even given freely from Peregrine to us-- but I find this interesting:

Both Video#1 and Video#2 are both produced in January 2014

Both Video#1 and Video#2 are both produced by the same company.... Tustin is far from NY/CT

Both Video#1 and Video#2 can complement one another (Bavi/or BB entering the blood brain barrier?)

Now ask... what are those probabilities that they (Peregrine), decides to use a video-animation company that their competitors use "OR" was this Roche behind it the entire time and why use two different companies for this video when you decrease risk of leaks heading out so you just use the very same company.

I mean why the hell would Peregrine use the same company... when everyone here knows, its nothing but silence.... till this latest "connect the dots..."

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97714553&txt2find=vimeo


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News